L'Oréal S.A. (LRLCF) H1 2025 Earnings Call Transcript

L'Oréal reported solid H1 2025 results, with like-for-like sales growth of 3% (accelerating to 3.7% in Q2, adjusted for IT transformation) and a record operating margin of 21.1%, up 30 basis points. Growth was broad-based across divisions, notably Professional Products (+6.5%) and Emerging Markets (+10.4%), though North Asia was hindered by a significant decline in Travel Retail. The company is confident in achieving 4% market growth for the full year, driven by an accelerated Beauty Stimulus Plan and strategic acquisitions like Medik8 and Color Wow, while actively managing the manageable impact of new U.S. tariffs on EU imports.

Analysis

L'Oréal delivered a solid H1 2025 performance, characterized by accelerating growth and record profitability despite regional and category-specific headwinds. The group reported like-for-like sales growth of 3%, with an adjusted sequential acceleration from 2.6% in Q1 to 3.7% in Q2, driven by a balanced contribution from volume (+1.2%) and value/mix (+1.7%). A key highlight was the record H1 operating margin of 21.1%, an increase of 30 basis points, showcasing disciplined cost management through tools like the BETiq A&P optimizer, even as gross margin compressed slightly by 10 bps. Performance was led by the Professional Products division (+6.5%) and strong double-digit growth in Emerging Markets (+10.4%). However, this strength was partially offset by a 1.1% decline in North Asia, a direct result of a high-teens negative performance in the Travel Retail channel, which masked a positive turn in Mainland China. By category, Haircare (+12.1%) and Perfumes (+11%) were the primary growth engines, while Skincare posted a slight decline, impacted by the North Asian market dynamics and tough suncare comparatives.

Management has reiterated its confidence in outperforming a global beauty market projected to grow around 4% for the full year, supported by an acceleration of its "Beauty Stimulus Plan" in H2, which is expected to add over 300 basis points from new product launches. The company also addressed the newly imposed 15% U.S. tariffs on EU imports, stating the impact is "manageable" at under 40 basis points for the year and will be mitigated through inventory management and potential price increases. Strategic acquisitions of high-growth brands Medik8 and Color Wow signal a clear intent to reinforce its portfolio in the premium skincare and prestige haircare segments. The overarching narrative remains focused on L'Oréal's evolution into a "Beauty Tech" company, leveraging AI to widen its competitive moat in R&D, marketing, and operations.

Key Decisions for Investors

• Investors should monitor the execution of the H2 'Beauty Stimulus Plan' as its success is critical for L'Oréal to achieve its goal of outperforming the projected 4% market growth and re-accelerating its Luxe and Consumer divisions.
• While H1 profitability was strong, the full impact of U.S. tariffs will materialize in H2; the company's ability to pass on price increases and find efficiencies to offset the sub-40 basis point margin headwind without hurting volumes is a key variable for full-year results.
• The stabilization in Mainland China is a positive development, but the significant drag from Travel Retail continues to suppress growth in North Asia, warranting close attention to the channel's structural reconfiguration.
• The slight decline in the Skincare category is a notable weakness, and a sustained rebound, driven by innovation and new acquisitions like Medik8, will be crucial for the group's long-term growth algorithm.